Acyclovir and Evoxac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Evoxac (cevimeline hydrochloride). Common drug interactions include diarrhoea among females and anaphylactic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Evoxac. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Evoxac?

Evoxac has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 2,028 Evoxac users. Check the latest studies of Evoxac.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

20 people who take Acyclovir and Evoxac together, and have interactions are studied.

Acyclovir and Evoxac drug interactions.

What are the common drug interactions of Acyclovir and Evoxac, by gender? *:

female:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Anxiety
  4. Arrhythmia (irregular heartbeat)
  5. Arthralgia (joint pain)
  6. Aura
  7. Death
  8. Dyspnoea (difficult or laboured respiration)
  9. Eye pain
  10. Fall

male:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Blood cholesterol increased
  3. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  4. Impaired healing
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Skin ulcer
  8. Dyspnoea (difficult or laboured respiration)
  9. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  10. Oxygen saturation decreased

What are the common drug interactions of Acyclovir and Evoxac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Blood cholesterol increased
  3. Dyspnoea (difficult or laboured respiration)
  4. Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
  5. Oxygen saturation decreased
  6. Sinusitis (inflammation of sinus)
  7. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Urinary tract infection
  10. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)

60+:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Pneumonia fungal
  5. Rash
  6. Blood glucose decreased
  7. Chest pain
  8. Cystitis (inflammation of the wall of the bladder)
  9. Pleuritic pain
  10. Abdominal pain upper

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 25.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 25.00%
  3. Drowsiness: 5 people, 25.00%
  4. Multiple Myeloma (cancer of the plasma cells): 5 people, 25.00%
  5. Migraine (headache): 4 people, 20.00%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  7. Insomnia (sleeplessness): 3 people, 15.00%
  8. Pain: 3 people, 15.00%
  9. Dry Mouth: 3 people, 15.00%
  10. Depression: 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Evoxac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Evoxac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evoxac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evoxac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and cevimeline hydrochloride (the active ingredients of Acyclovir and Evoxac, respectively), and Acyclovir and Evoxac (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: